Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05YBG
|
|||
| Drug Name |
PMID25468267-Compound-51
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
EPITHERAPEUTICS APS
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H17N3O2
|
|||
| Canonical SMILES |
CN(C)CCNCC1=NC=CC(=C1)C(=O)O
|
|||
| InChI |
1S/C11H17N3O2/c1-14(2)6-5-12-8-10-7-9(11(15)16)3-4-13-10/h3-4,7,12H,5-6,8H2,1-2H3,(H,15,16)
|
|||
| InChIKey |
SAAOFVWGGZSWSS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lysine-specific demethylase 4 (KDM4) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Lysine-specific demethylase 4 (KDM4) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.